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hen the clinician-scientist Dr. D. Martin 
Carter died last November of a ruptured dis-
secting aortic aneurysm, dermatology lost one 
of its major figures, and I, with many, many 
others, lost a close friend. 
Martin Carter was born in 1936 in Doniphan, Missouri. His 
formative years were spent in nearby Springfield, where he attended 
high school. From an early age Martin made plans to become a 
physician: descending from a large family of educators, ministers, 
and physicians, Martin Carter believed that medicine would offer 
him a life of community service. 
He was accepted to most colleges he applied to, including Yale. 
He chose Dartmouth because, as a Daniel Webster National 
Scholar, the full cost of his undergraduate years would be paid for. 
So, at age 18 and on his own, he boarded a bus in Springfield, 
Missouri, for Hanover, New Hampshire. 
He was graduated from Dartmouth with an A.B. degree in 1958, 
and in 1959, after two years of medical study at Dartmouth, he 
entered Harvard Medical School from which he received his M.D. 
in 1961. Subsequently he was a house officer in a mixed surgicalj 
medical rotation at the University of Rochester (1961- 1963); a 
fellow at the Center for Disease Control (CDC) in Atlanta, Georgia 
(1963 -1965); and a resident in dermatology at the University of 
Pennsylvania (1965 -1967). During his assignment at the CDC and 
his residency at Penn, in discussions with Dr. George Hambrick, he 
decided to go into academic dermatology. 
Even though Martin had been keenly interested in genetics, he 
had no experience in research. Marty and his wife paid a visit to 
New Haven in December 1966 to discuss with me and my wife, 
Marguerite, how best to prepare for an academic career. At that 
time, Yale had a medical research training program in which train-
ees were enrolled as fellows in a particular department, or in the 
Graduate School to work towards a Ph.D degree. Never one to take 
a short cut, Martin decided on the latter, more difficult route and 
chose as his adviser Dr. Charles Radding, an outstanding molecular 
biologist interested in mechanisms of DNA damage and repair. 
After Martin received the Ph.D. degree from Yale in 1971 and 
joined the Dermatology faculty, promotions came quickly. He rose 
to full professor in 1977, and he was Yale's first Howard Hughes 
Medical Investigator, a title he held for seven years. Martin had 
research, clinical, teaching, and administrative responsibilities. He 
carried out research in photobiology, aging, and genetics, set up our 
UV -psoralen treatment center, and pushed for the growth of our 
Department. 
In 1981, after a stellar performance at Yale, he accepted the chal-
lenge of establishing a Laboratory for Investigative Dermatology at 
Rockefeller University as Professor and Senior Physician and, last 
year, was made the Carl J. Herzog Professor of Clinical Investiga-
tion. In addition to his activities at Rockefeller, he served as Profes-
sor of Dermatology at New York Hospital-Cornell Medical 
Center, where he, together with Hambrick, brought Cornell der-
matology into departmental status. 
In his research activities in photobiology, Carter studied the ef-
fects of psoralens and light on cell proliferation and defined light-
stimulated interactions of DNA with psoralens, especially 8-meth-
oxy- and trimethyl-psoralens, such as DNA interstrand crosslinking 
and the promotion of sister chromatid exchange. He related these 
findings to the treatment of psoriasis and vitiligo and the risk of 
cutaneous carcinogenesis. He was a participant in the original na-
tional study group of PUV A treatment for psoriasis and vitiligo. 
Carter was also interested in the interactions between environmen-
tal agents, age, and genetic factors on the skin. In the context of 
investigations on wound healing, he and associate Arthur Bailin 
studied the cytotoxic effects of high levels of oxygen on keratino-
cytes in culture and established that the life span of these cells could 
be extended as much as fivefold when they were grown under 
conditions of reduced oxygen tension. 
His organizational talents were manifold. Carter's group was a 
referral center for patients with psoriasis, epidermolysis bullosa, 
Fanconi's anemia, and slow healing wounds. Martin was a member, 
officer, Or director of most national dermatologic societies, a past 
president of the Society for Investigative Dermatology, a founding 
member of the National Epidermolysis Bullosa Registry and of the 
American Skin Association. And, for a time, he chaired the Execu-
tive Committee at Rockefeller. 
In any writing on Martin Carter one should include at least a few 
comments on his special traits and personal life. Marty had a win-
ning personality. Optimism, hard work, and fair play made him a 
leader as well as a role model for many young faculty. His sound 
judgment and persuasive ways helped resolve many an interpersonal 
dispute. He was always supportive of students, house officers, and 
colleagues, and many of them sought his advice. Martin loved 
music-especially opera and singing groups-and loved to sing: 
Gathering around the piano for a songfest was a highlight of many 
parties at his home. 
At the base of all these admirable qualities was a wonderful and 
close family: his wife, Anne ("Jill") Babson Carter; two daughters, 
Anna Carter Florence and Elizabeth Carter Rooney; a SOil, Chris-
topher Hart Martin Carter; his father, Joseph Martin Carter; a 
brother, Dr. James Leighton Carter; and one grandchild, 2V2-year-
old Caleb Martin Florence. It was a source of much pride to him that 
his brother James and daughter Anna are third and fourth genera-
tion ordained Presbyterian ministers, while he himself was a ruling 
elder at Madison Avenue Presbyterian Church in New York City. 
Martin- you touched our lives in an infinite number of mean-
ingful ways. 
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